Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer

Exclusion Criteria

• •You cannot participate in this study if any of the following apply to you:
• •Age \< 18 years
• •History of previous malignancies
• •Women pregnant or lactating
• •History or physical exam evidence of central nervous system disease)
• •Active infection requiring intravenous antibiotics
• •Full-dose anticoagulation or thrombolytic therapy within 10 days
• •Proteinuria.
• •Serious nonhealing wound, ulcer, or bone fracture
• •Evidence if bleeding diathesis or coagulopathy
• •History of heart attack within 6 months.
• •Uncontrolled cardiovascular disease
• •PEG or G-tube
• •History of other serious disease